Complementary Medicines Australia appoints new CEO
Complementary Medicines Australia (CMA) has announced the appointment of John O'Doherty as the new Chief Executive & Public Officer of the peak body for the complementary medicines industry supply chain.
John O'Doherty will step into the role from 1 July 2023, following the retirement of Carl Gibson.
Making the announcement Ben Rowe, CMA President said; “Following an independent and extensive recruitment search by Horizon One, CMA is pleased to announce the appointment of John O'Doherty as the new CEO. John will build on our healthy foundations and take the organisation to the next level with his outstanding communication and his proven track record in government advocacy.”
Having worked in the complementary medicines sector since 2018, John understands the issues that matter most to the industry, and the critical importance of CMA continuing to take a prominent role to promote and protect the sector.”
John is a senior business leader with extensive experience across Public Affairs, Government Relations, Corporate Affairs, media/communications, and law, finance and governance.
John has been on the CMA Board since early 2020 and is currently Chair of the Political Committee.
Following the appointment John O'Doherty said; “I am incredibly excited to be joining the team at CMA and leading the organisation into the future. CMA plays a critical role in supporting, promoting and advancing the interests of members and the industry. I am committed to seeing the industry continue to go from strength to strength. Key to this will be getting the regulatory and policy settings right – both in Australia and in key export markets. This will help drive innovation, grow manufacturing, and achieve greater recognition and government support for our industry.”
Ben Rowe added; “CMA is incredibly grateful to Carl Gibson for his 10 years of passionate and dedicated service, successfully delivering key reforms and he is leaving the organisation in a healthy position. We wish him a healthy and happy retirement.”
Taken from Complementary Medicines Australia Media Release on 27 April 2023.